Effect of NT-proBNP on Serum Calcium: A Longitudinal Analysis

<i>Background and Objectives</i>: Brain natriuretic peptide (NT-proBNP) is a biomarker widely used in diagnosing and monitoring heart failure. Its impact on electrolyte homeostasis is known, particularly for sodium. However, its relationship with serum calcium remains unclear. This retrospective observational study aimed to investigate the longitudinal association between NT-proBNP and serum calcium levels in a cohort of hospitalized patients with the goal of determining whether NT-proBNP could have a direct or indirect impact on calcium metabolism. <i>Materials and Methods</i>: We included 688 patients with 1022 repeated measurements of NT-proBNP and serum calcium collected during hospitalization from March 2022 to February 2025. Linear mixed models (LMMs) were employed to analyze longitudinal associations, adjusting for age, eGFR, estimated plasma volume status (ePVs), CRP, potassium, and albumin. <i>Results</i>: Baseline analysis revealed a negative correlation between NT-proBNP and serum calcium (r = -0.23, <i>p</i> < 0.001). Univariate LMM demonstrated a significant negative association (β = -1.3 × 10<sup>-5</sup>, <i>p</i> < 0.001), which remained significant in multivariate analysis (β = -6.9 × 10<sup>-6</sup>, <i>p</i> = 0.01), accounting for intrasubject variability. This suggests that as NT-proBNP increases, serum calcium levels decrease within individual patients, independent of confounders. This study's findings indicate that NT-proBNP may influence calcium excretion, possibly through mechanisms involving the sodium-calcium exchanger (NCX) in renal tubules, similar to its effects on sodium homeostasis. <i>Conclusions</i>: This is the first study to evaluate the longitudinal impact of NT-proBNP on serum calcium, highlighting a potential clinical relevance in patients with cardiac dysfunction. Limitations include a retrospective design and a lack of urine calcium data. Further research is warranted to validate these findings and elucidate the underlying mechanisms.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2025-04-19
DOI
https://doi.org/10.3390/medicina61040755
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of NT-proBNP on Serum Calcium: A Longitudinal Analysis

Cheyenne J. Cannarozzo, Rossella Salemi, Elisa Longhitano, Thea Corriere et al.
Medicina
Heart Failure Treatment and Management
article

Effect of NT-proBNP on Serum Calcium: A Longitudinal Analysis

Cheyenne J. Cannarozzo, Rossella Salemi, Elisa Longhitano, Thea Corriere, Maria Eva Sberna, Maria Rita Stancanelli, Vincenzo Calabrese, Ada Restivo, María Cristina Ferrara, Giuseppe Restivo, Domenico Santoro, Valeria Furia, Angelo Iraci
article en

Abstract

<i>Background and Objectives</i>: Brain natriuretic peptide (NT-proBNP) is a biomarker widely used in diagnosing and monitoring heart failure. Its impact on electrolyte homeostasis is known, particularly for sodium. However, its relationship with serum calcium remains unclear. This retrospective observational study aimed to investigate the longitudinal association between NT-proBNP and serum calcium levels in a cohort of hospitalized patients with the goal of determining whether NT-proBNP could have a direct or indirect impact on calcium metabolism. <i>Materials and Methods</i>: We included 688 patients with 1022 repeated measurements of NT-proBNP and serum calcium collected during hospitalization from March 2022 to February 2025. Linear mixed models (LMMs) were employed to analyze longitudinal associations, adjusting for age, eGFR, estimated plasma volume status (ePVs), CRP, potassium, and albumin. <i>Results</i>: Baseline analysis revealed a negative correlation between NT-proBNP and serum calcium (r = -0.23, <i>p</i> < 0.001). Univariate LMM demonstrated a significant negative association (β = -1.3 × 10<sup>-5</sup>, <i>p</i> < 0.001), which remained significant in multivariate analysis (β = -6.9 × 10<sup>-6</sup>, <i>p</i> = 0.01), accounting for intrasubject variability. This suggests that as NT-proBNP increases, serum calcium levels decrease within individual patients, independent of confounders. This study's findings indicate that NT-proBNP may influence calcium excretion, possibly through mechanisms involving the sodium-calcium exchanger (NCX) in renal tubules, similar to its effects on sodium homeostasis. <i>Conclusions</i>: This is the first study to evaluate the longitudinal impact of NT-proBNP on serum calcium, highlighting a potential clinical relevance in patients with cardiac dysfunction. Limitations include a retrospective design and a lack of urine calcium data. Further research is warranted to validate these findings and elucidate the underlying mechanisms.

MedicinaVol. 61(4)
Università degli Studi di Enna Kore (IT)
Openalex Percentile: Top 86%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.